MYDGF and metabolic dysfunction-associated steatotic liver disease: MYDGF has also been linked to the recurrence risk of non-alcoholic fatty liver disease (NAFLD), where its absence worsens liver index, lipogenesis, and liver dysfunction while restoring it mitigates these effects.